Perivascular epithelioid cell tumor of the rectum: report of a case and review of the literature by Amane Kanazawa et al.
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Kanazawa et al. World Journal of Surgical Oncology 2014, 12:12
http://www.wjso.com/content/12/1/12CASE REPORT Open AccessPerivascular epithelioid cell tumor of the rectum:
report of a case and review of the literature
Amane Kanazawa1*, Shoichi Fujii1, Ten-i Godai1, Atsushi Ishibe1, Takashi Oshima1, Tadao Fukushima1,
Mitsuyoshi Ota1, Norio Yukawa2, Yasushi Rino2, Toshio Imada2, Junko Ito3, Akinori Nozawa3,
Munetaka Masuda2 and Chikara Kunisaki1Abstract
We report a case of perivascular epithelioid cell tumor arising in the rectum of a 55-year-old woman. The tumor
was treated by transanal endoscopic microsurgery. After 1 year follow-up, the patient is alive with no radiologic or
endoscopic evidence of recurrence. Perivascular epithelioid cell tumor is a rare mesenchymal tumor characterized
by co-expression of melanocytic and smooth muscle markers. This rare tumor can arise in various organs, including
the falciform ligament, uterus, uterine cervix, liver, kidney, lung, breast, cardiac septum, pancreas, prostate, thigh,
and gastrointestinal tract. Perivascular epithelioid cell tumor of the gastrointestinal tract is very rare, with only 23
previously reported cases. We review the literature on perivascular epithelioid cell tumors arising in the
gastrointestinal tract.
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Perivascular epithelioid cell tumors (PEComas) were de-
fined as “mesenchymal tumours composed of histologi-
cally and immunohistochemically distinctive perivascular
epithelioid cells” by the World Health Organization [1].
PEComas classically include a wide spectrum of entities,
such as angiomyolipoma (AML), lymphangioleiomyoma-
tosis (LAM), and clear-cell “sugar” tumors (CCST) of the
lung. PEComas other than AML, LAM, and CCST are
very rare mesenchymal tumors that have been referred to
as PEComa-not otherwise specified (PEComa-NOS) [1,2].
A review of 51 cases of PEComa-NOS revealed that 41%
of reported cases of PEComa-NOS originated in the uter-
ine corpus [3].
Gastrointestinal PEComa-NOS are very rare. To our
knowledge, 23 cases have been reported in the literature
[4-22]; consequently, the clinical and biological charac-
teristics of PEComa-NOS are poorly understood. We re-
port a case of PEComa arising in the rectum and review
the clinicopathological characteristics of gastrointestinal
PEComa-NOS.* Correspondence: amanex2009@gmail.com
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A 55-year-old woman was referred to our hospital because
of a rectal submucosal tumor detected on a colonoscopic
examination. She had undergone a sigmoidectomy for
sigmoid colon carcinoma 2 years previously in our hos-
pital. Postoperatively, the final disease stage was T1N0M0
(Stage I) according to the TNM classification. The histo-
logical subtype of the sigmoid colon cancer was moder-
ately differentiated adenocarcinoma. There had been no
evidence of recurrence or metastasis during 2 years
follow-up. The patient showed no signs of tuberous scler-
osis complex.
On digital rectal examination, a hard mass was pal-
pated on the posterior wall of the rectum. The results of
other physical examinations of the abdomen and other
organs were normal. Laboratory data showed no marked
abnormalities, including tumor markers such as carci-
noembryonic antigen and carbohydrate antigen 19-9.
Colonoscopic examination in our hospital revealed a
submucosal tumor 3 cm in diameter arising in the pos-
terior rectal wall, 10 cm from the anal verge (Figure 1a).
The submucosal tumor was accompanied by an ulcer
and superficial mucosal bleeding at its center. A biopsy
was performed, but a histopathological diagnosis could
not be established. An endoanal ultrasound scan showedral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Findings on colonoscopy and endoanal ultrasound scanning. (a) Colonoscopic examination showed a submucosal tumor 3 cm in
diameter arising in the posterior rectal wall. (b) Endoanal ultrasound scanning showed a heterogeneous, low-echoic tumor with a nodular
appearance arising in the muscularis (long arrow) of the posterior rectal wall.
Figure 2 Appearance of tumor stained with hematoxylin and
eosin. The tumor consisted of round and polygonal cells with
clear-to-eosinophilic granular cytoplasm. The tumor cells proliferated
in a honeycomb-like fashion.
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muscularis of the posterior rectal wall (Figure 1b). The
tumor was suspected to invade the muscularis propria
and subserosa. Contrast-enhanced computed tomog-
raphy of the chest, abdomen, and pelvis detected no
lymph node lesions around the rectum or metastasis to
other organs.
The patient underwent transanal endoscopic microsur-
gery for a suspected diagnosis of rectal stromal tumor.
We excised the full-thickness of the rectal wall excision
with a 1 cm safety margin of normal mucosa around the
tumor. The wound in the rectal wall was closed with a
running suture. Macroscopically, the resected specimen
showed a brown mass 2.5 cm in maximum diameter,
with a central ulcer, an ill-defined border, and no capsule
formation. Surface ulceration was prominent in associ-
ation with absence of the rectal mucosa, which was as-
cribed to a prior endoscopic biopsy.
On microscopic examination, the tumor resided mainly
in the musclaris propria and invaded the mucosa and was
exposed on its surface. Histopathologically, the tumor
consisted of round and polygonal cells with clear-to-
eosinophilic granular cytoplasm. The tumor cells prolifer-
ated in a honeycomb-like appearance (Figure 2). The tumor
cell nuclei showed hyperchromasia, nuclear enlargement,
and prominent nucleoli. The tumor cells were negative for
Fontana-Masson staining. Periodic acid-Schiff stain-positive
intracytoplasmic granules, which were digested by diastage,
were noted. The tumor cell showed slight to moderate nu-
clear atypia, with no mitosis or tumor necrosis. There was
no lymphatic or vascular invasion.
Immunohistochemically, the tumor cells were positive
for melanoma-associated antigen (HMB-45), neuron-
specific enolase, CD68, and transcription factor E3(TFE-3), but negative for AE1/AE3, CAM5.2, epithelial
membrane antigen, smooth muscle actin, Desmin,
MyoD1, Caldesmon, Calponin, Synaptophysin, Chromo-
granin A, NCAM, Vimetin, CD34, S-100, Melan-A,
CD99, CD10, D2-40, CD138, P-ALP, and multiple mye-
loma oncogene-1 (Figure 3ab). The proliferation marker
Ki-67 showed a nuclear positivity in approximately 15%
of cells. An intestinal PEComa was diagnosis on the
basis of these findings. This patient received only surgi-
cal resection. She is undergoing regular surveillance and
remains free of disease at 15 months after operation.
Discussion
PEComas are part of a group of very rare mesenchymal
neoplasms. Bonetti and colleagues [23] were the first to
propose the concept of the perivascular epithelioid cell
ab
Figure 3 Immunohistochemical findings of the tumor. (a) HMB-45 is positive in the cytoplasm of the tumor cells. (b) Nuclear expression of
TFE3 is observed in the tumor cells. HMB-45, melanoma-associated antigen; TFE3, transcription factor E3.
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colleagues [24] in 1996 to describe this rare family of le-
sions. In 2002, the World Health Organization accepted
the designation PEComa as a distinct mesenchymal neo-
plasm consisting of histologically and immunohistochemi-
cally unique perivascular epithelioid cells [1]. This rare
tumor has been reported in various organs, such as the fal-
ciform ligament, uterus, uterine cervix, liver, kidney, lung,
breast, cardiac septum, pancreas, prostate, thigh, and
gastrointestinal tract. PEComas usually show immunoreac-
tivity for both melanocytic (HMB-45 and/or melan-A) and
smooth muscle (actin and/or desmin) markers. Recently,
several reports described TFE3 expression in PEComas
[14,22,25]. In one review, TFE3 was positive for 3 of 24
cases of gastrointestinal PEComa. In our case, positivity for
TFE3 contributed to the diagnosis of PEComa.
In this study, we focused on gastrointestinal PEComa-
NOS and did not include classic AML and LAM of thegastrointestinal tract in our review. The clinicopatholog-
ical features of the PEComa-NOS included in this study
are summarized in Table 1. The ratio of males to women
was 8 to 16, suggesting that primary gastrointestinal
PEComa-NOS is more common in females, similar to
PEComa-NOS arising in other organs. Mean age at the
diagnosis of primary gastrointestinal PEComa-NOS was
31.5 years (range 7 to 63 years). The mean diameter of
primary gastrointestinal PEComa-NOS was 45.5 mm
(range 12 to 100 mm). The tumor was located in the
colon in 14 patients (58.3%), rectum in 5 (20.8%), the
small bowel in 2 (8.3%), the duodenum in 2 (8.3%), and
the stomach in 1 (4.3%). Surgical resection was per-
formed in nearly all patients, and only two received ad-
juvant chemotherapy. One patient was given adjuvant
interferon-α2b therapy, and the other case received adju-
vant chemotherapy with doxorubicin, ifosfamide, and
mesna in accordance with the Children’s Oncology
Table 1 Patient characteristics and tumor morphologic and histopathological features and outcomes
Year Author [reference] Age
(years)







2001 Tazelaar et al., [4] 9 F Rectum 30 - Rare - - Trans anal resection - NER at 14 months
2001 Tazelaar et al., [4] 40 F Rectum 80 - Rare - - Excision - NER at 6 months
2003 Yanai et al., [5] 32 F Jejunum 75 - n.a - + Partial resection of jejunum - Pelvic wall recurrence at 13 months, Right
ovary recurrence at 25 months
2004 Birkahaeuser et al., [6] 35 F Cecum 35 n.a Few n.a - Right hemicolectomy - n.a
2004 Genevay et al., [7] 38 F Cecum 35 n.a Rare n.a - Right hemicolectomy n.a n.a
2005 Evert et al., [8] 58 F Rectum 80 n.a 286 n.a + n.a n.a n.a
2005 Yamamoto et al., [9] 43 F Descending 80 n.a 2 + + Partial colectomy - Peritoneal dissemination at 20 months, DOD
at 38 months
2005 Mhanna et al., [10] 15 M Duodenum 45 + Low n.a - Pancreaticoduodenectomy - NER at 24 months
2006 Baek et al., [11] 16 F Transverse 25 n.a 0 n.a - Endoscopic resection - NER at 24 months
2006 Agimy et al., [12] 63 F Ileum 45 n.a 13 n.a + Partial resection of ileum - Abdominopelvic recurrence at 14 months
2008 Narayanaswamy et al., [13] 34 M Duodenum 35 + n.a - - Duodenectomy - NER at 18 months
2008 Cho et al., [14] 16 F Transverse 18 n.a n.a - - n.a - NER at 41 months
2008 Pisharody et al., [15] 11 M Sigmoid 12 n.a Rare n.a n.a Partial colectomy - NER at 5 months
2008 Righi et al., [22] 11 M Sigmoid 35 + Rare n.a + Segmental resection - n.a
2009 Ryan et al., [16] 15 F Rectum 37 - 2 - + Low anterior resection + NER at 9 months
2009 Qu et al., [17] 43 F Cecum 20 - 3 - - Right hemicolectomy - NER at 25 months
2010 Park et al., [18] 7 M Ascending 37 n.a n.a n.a n.a Right hemicolectomy + NER at 26 months
2010 Shi et al., [19] 38 F Sigmoid 60 n.a n.a n.a - Segmental resection - NER at 8 months
2010 Shi et al., [19] 42 M Ascending 45 n.a n.a n.a - Segmental resection - NER at 15 months
2010 Shi et al., [19] 38 F Descending 48 n.a n.a n.a - Segmental resection - NER at 32 months
2010 Shi et al., [19] 45 M Ascending 35 n.a n.a n.a - Segmental resection - NER at 36 months
2010 Freeman et al., [21] 17 F Sigmoid 60 - Low n.a n.a Partial resection - NER at 15 months
2012 Waters et al., [20] 42 M Gastric 100 n.a n.a n.a n.a Distal gastrectomy - DOD at 3 months
2012 Present case 55 F Rectum 25 + 0 - - Trans anal resection - NER at 12 months
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protocol. Neither of these patients had any evidence of
recurrence. Follow-up data were available for 19 pa-
tients, and the median follow-up was 15 months (range
3 to 41 months) after surgery. Three cases had recur-
rence [5,12], two of whom underwent re-resection of
their tumors. The 3-year disease free survival rates of
the 19 patients was 75%. Two patients died of their dis-
ease. One patient died 3 months after surgery, and the
other died 38 months after the first operation.
Although the treatment of choice for gastrointestinal
PEComa is surgical resection, the overall management
strategy for gastrointestinal PEComa remains to be
established. Furthermore, potential benefits of adjuvant
chemotherapy have not been investigated. In a recent
study of PEComa of soft tissue and gynecologic origin,
Folpe and colleagues [25] suggested criteria for classify-
ing PEComas into benign, uncertain malignant potential,
and malignant categories. They proposed that malig-
nancy was predicted by the presence of two of the
following findings: tumor size greater than 5 cm, infiltra-
tive tumor border, high nuclear grade and cellularity,
more than 1 mitosis/50 high-power fields, tumor necro-
sis, and vascular invasion. In our patient, the tumor was
classified as low grade according to these diagnostic cri-
teria because there was an infiltrative tumor border, but
none of the other findings.
Given the present situation, close follow-up, including
imaging studies and colonoscopy, is mandatory after sur-
gical resection of gastrointestinal PEComa, especially in
patients with high-grade malignancy. Because the out-
comes of gastrointestinal PEComa remain unclear, fur-
ther long-term studies in larger number of patients are
needed.
Conclusions
We reported a rare case of rectal PEComa and reviewed
the clinicopathological characteristics of gastrointestinal
PEComa-NOS. At the present time, the most effective
treatment for gastrointestinal PEComa is surgical resec-
tion. But the postoperative management including adju-
vant chemotherapy still has not been established. So
patients with postoperative PEComa-NOS should be
carefully followed up.
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